Pacira Biosciences Inc. (pcrx 0.75 08/01/25)

13F holders, Q2 2024 (June 30)
6holders
2new positions
2sold out
$0.94avg. 13F price*

At the end of Q2 2024, 6 institutions reported holding Pacira Biosciences Inc. (pcrx 0.75 08/01/25) in their 13F filings, unchanged from Q1 2024. 2 opened new positions and 2 sold out. The largest holders were Cetera Investment Advisers ($136K), Choreo, LLC ($22K) and Kestra Advisory Services, LLC ($15K).

Company
Pacira Biosciences Inc. (pcrx 0.75 08/01/25)
CUSIP
695127AF7
Latest filing quarter
Q2 2025

History

Number of 13F holders

0246810 Q1 2024: 6Q1 2024Q2 2024: 6Q2 2024Q3 2024: 6Q3 2024Q4 2024: 8Q4 2024Q1 2025: 10Q1 2025Q2 2025: 9Q2 2025

Total Exit/New Position Q1 2024 → Q2 2024

InstitutionsTotal Value
New Positions2$31K
Exits2$663K

All 13F filers, Q1 2024 → Q2 2024: 33,000 shares bought and 699,000 shares sold, net −666,000 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 6 holders

Cetera Investment Advisers 0.00% No change 145,000 $136K
Choreo, LLC 0.00% New 23,000 $22K
Kestra Advisory Services, LLC 0.00% No change 16,000 $15K
Boston Financial Mangement LLC 0.00% No change 12,000 $11K
Sensible Money, LLC 0.00% No change 10,000 $9K
Asset Dedication, LLC 0.00% New 10,000 $9K

"% of holder's portfolio" is PACIRA BIOSCIENCES INC (PCRX 0.75 08/01/25)'s weight in each manager's 13F, not the share of Pacira Biosciences Inc. (pcrx 0.75 08/01/25) the manager owns.